Category: Federal Forum Posters
Purpose: Regenstrief National Center for Medical Device Informatics (REMEDI) is a collaborative community involving pharmacists, nurses, physicians, and vendors. Medication error is high for drugs administered through an infusion pump. Therefore, REMEDI is a way to improve patient safety and quality through the exchange and analysis of infusion pump data and best practices. Hospitals are able to perform self-analysis of medication use through the pump analytics included in the system. The objective of this project is to analyze alteplase, a high-alert medication, across 259 institutions to determine best practices and reduce medication errors to ensure patient safety.
Methods: This study will be submitted to the Institutional Review Board for approval. The REMEDI science gateway will be used to provide access to infusion pump libraries, compliance, and alerts across 259 institutions. The library will be used to identify and display data for all participating institutions who have administered alteplase via infusion pumps. The following data pertaining to alteplase will be collected: indications, concentrations, any soft or hard minimums and maximums set, and how it was delivered. Each administration within the involved institutions will be recorded and all data will be reviewed. The analysis will compare the pre-determined concentrations, as well as limit settings, within the infusion pump at each institution. In addition, commonly used alerts associated with alteplase when administering it through an infusion pump will be reviewed and reported. The resulting data from this project will be used to provide evidence-based recommendations to improve patient safety when administering alteplase via an infusion pump.
Danya Faruqi– Medication Safety Fellow, Purdue University, Dundee, IL